Search

Displaying results 4551 - 4560 of 10000 in total
  1. Drug

    Ioxabrolic acid

    go.drugbank.com/drugs/DB20915
    Experimental

    Ioxabrolic acid is a small molecule drug. Ioxabrolic acid has a monoisotopic molecular weight of 1124.61 Da.

  2. Drug

    Triamcinolone furetonide

    go.drugbank.com/drugs/DB21010
    Experimental

    Triamcinolone furetonide is a small molecule drug. Triamcinolone furetonide has a monoisotopic molecular weight of 578.23 Da.

  3. Drug

    Sorbitan trioleate

    go.drugbank.com/drugs/DB21103
    Experimental

    Sorbitan trioleate is a small molecule drug. Sorbitan trioleate has a monoisotopic molecular weight of 956.8 Da.

  4. Drug

    Bensuldazic acid

    go.drugbank.com/drugs/DB21135
    Experimental

    Bensuldazic acid is a small molecule drug. Bensuldazic acid has a monoisotopic molecular weight of 282.05 Da.

  5. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid is a small molecule drug. Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  6. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid is a small molecule drug. Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  7. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid is a small molecule drug. Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  8. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid is a small molecule drug. Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  9. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil is a small molecule drug. Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  10. Drug

    Tovorafenib

    go.drugbank.com/drugs/DB15266
    ApprovedInvestigational

    Tovorafenib is a selective type II RAF kinase inhibitor with anti-tumour activity. … [A263597] It was granted accelerated approval by the FDA, making it the first FDA approval of a systemic therapy for the treatment of pediatric low-grade glioma, with BRAF rearrangements.

    Synonyms: 4-Pyrimidinecarboxamide, 6-amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-, 6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide